
Personalis PSNL
$ 9.43
0.59%
Quarterly report 2025-Q3
added 11-04-2025
Personalis DIO Ratio 2011-2026 | PSNL
Annual DIO Ratio Personalis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 12.1 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.1 | 12.1 | 12.1 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
243 | $ 35.56 | 4.4 % | $ 383 M | ||
|
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
BioNano Genomics
BNGO
|
245 | $ 1.25 | -3.46 % | $ 1.59 M | ||
|
Castle Biosciences
CSTL
|
48.7 | $ 39.78 | 1.0 % | $ 1.1 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
304 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
92.9 | $ 221.78 | 1.32 % | $ 162 B | ||
|
Exact Sciences Corporation
EXAS
|
240 | $ 102.48 | 0.13 % | $ 19 B | ||
|
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | ||
|
DexCom
DXCM
|
119 | $ 73.26 | 0.29 % | $ 28.3 B | ||
|
Guardant Health
GH
|
78.4 | $ 115.14 | 0.96 % | $ 14.1 B | ||
|
CareDx, Inc
CDNA
|
48.3 | $ 20.53 | -0.1 % | $ 1.1 B | ||
|
DarioHealth Corp.
DRIO
|
165 | $ 11.0 | 9.78 % | $ 312 M | ||
|
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
7.17 | $ 26.16 | -0.15 % | $ 791 M | ||
|
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | ||
|
IDEXX Laboratories
IDXX
|
91.6 | $ 626.23 | -6.6 % | $ 51.6 B | ||
|
Illumina
ILMN
|
137 | $ 141.84 | -2.05 % | $ 22.6 B | ||
|
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B | ||
|
Lantheus Holdings
LNTH
|
44.2 | $ 67.23 | 0.47 % | $ 4.65 B | ||
|
NeoGenomics
NEO
|
25.1 | $ 12.22 | 1.29 % | $ 1.55 B | ||
|
Charles River Laboratories International
CRL
|
35.3 | $ 211.68 | 0.52 % | $ 10.9 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 28.84 | 0.47 % | $ 20 B | ||
|
Quest Diagnostics Incorporated
DGX
|
10.4 | $ 182.8 | -2.23 % | $ 20.3 B | ||
|
Precipio
PRPO
|
21.7 | $ 25.0 | 1.92 % | $ 32.4 M | ||
|
Laboratory Corporation of America Holdings
LH
|
18.8 | $ 267.65 | -1.42 % | $ 22.5 B | ||
|
ICON Public Limited Company
ICLR
|
0.213 | $ 178.11 | -1.19 % | $ 14.7 B | ||
|
Agilent Technologies
A
|
97.1 | $ 134.19 | 0.24 % | $ 40.8 B | ||
|
Biomerica
BMRA
|
147 | $ 2.38 | 0.18 % | $ 5.47 M | ||
|
OpGen
OPGN
|
459 | - | -16.95 % | $ 1.54 M | ||
|
Bioventus
BVS
|
175 | $ 8.15 | 2.84 % | $ 511 M |